PL3544972T3 - Heteroarylofenoksybenzamidowe ligandy opioidowe kappa - Google Patents

Heteroarylofenoksybenzamidowe ligandy opioidowe kappa

Info

Publication number
PL3544972T3
PL3544972T3 PL17818281.2T PL17818281T PL3544972T3 PL 3544972 T3 PL3544972 T3 PL 3544972T3 PL 17818281 T PL17818281 T PL 17818281T PL 3544972 T3 PL3544972 T3 PL 3544972T3
Authority
PL
Poland
Prior art keywords
heteroarylphenoxy
benzamide
kappa opioid
opioid ligands
ligands
Prior art date
Application number
PL17818281.2T
Other languages
English (en)
Polish (pl)
Inventor
Kapildev Kashmirilal ARORA
Michael Aaron Brodney
Matthew Francis DUNN
Michael Eric GREEN
Natasha Mariam KABLAOUI
Gregory Wayne KAUFFMAN
Scot Richard MENTE
Justin Ian Montgomery
Danica Antonia RANKIC
Bruce Nelsen Rogers
Patrick Robert Verhoest
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL3544972T3 publication Critical patent/PL3544972T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL17818281.2T 2016-11-28 2017-11-27 Heteroarylofenoksybenzamidowe ligandy opioidowe kappa PL3544972T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662426980P 2016-11-28 2016-11-28
US201762576435P 2017-10-24 2017-10-24
US201762585016P 2017-11-13 2017-11-13
PCT/IB2017/057418 WO2018096510A1 (en) 2016-11-28 2017-11-27 Heteroarylphenoxy benzamide kappa opioid ligands

Publications (1)

Publication Number Publication Date
PL3544972T3 true PL3544972T3 (pl) 2023-07-24

Family

ID=60782279

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17818281.2T PL3544972T3 (pl) 2016-11-28 2017-11-27 Heteroarylofenoksybenzamidowe ligandy opioidowe kappa

Country Status (18)

Country Link
US (1) US10316021B2 (https=)
EP (1) EP3544972B8 (https=)
JP (1) JP7051853B2 (https=)
CN (1) CN110234638B (https=)
AU (1) AU2017365123B2 (https=)
DK (1) DK3544972T3 (https=)
ES (1) ES2947293T3 (https=)
FI (1) FI3544972T3 (https=)
HR (1) HRP20230518T1 (https=)
HU (1) HUE061945T2 (https=)
IL (1) IL266962B (https=)
MX (1) MX389806B (https=)
PH (1) PH12019501172A1 (https=)
PL (1) PL3544972T3 (https=)
PT (1) PT3544972T (https=)
RS (1) RS64258B1 (https=)
TW (1) TWI720272B (https=)
WO (1) WO2018096510A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
EP3585485A2 (en) 2017-02-24 2020-01-01 Xeniopro GmbH Aromatic compounds which enhance notch signaling, for use in therapy
US11266627B1 (en) 2021-05-04 2022-03-08 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
CN111233768B (zh) * 2020-03-18 2021-08-03 徐州圣元化工有限公司 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法
KR20210151949A (ko) * 2020-04-05 2021-12-14 화이자 인코포레이티드 Covid-19의 치료를 위한 화합물 및 방법
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
AU2023231493A1 (en) * 2022-03-07 2024-10-24 Janssen Pharmaceuticals, Inc. Pure forms of crystalline aticaprant
WO2023170554A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Compositions comprising aticaprant
WO2023170550A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Polymorph forms of aticaprant for use in treating major depressive disorder
AR130742A1 (es) * 2022-10-12 2025-01-15 Adama Makhteshim Ltd Proceso para la preparación de derivados de aminopiridazina

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
AU5653799A (en) 1998-09-21 2000-04-10 Takeda Chemical Industries Ltd. Novel thiol derivatives, process for producing the same and utilization thereof
JP2000159747A (ja) * 1998-09-21 2000-06-13 Takeda Chem Ind Ltd 新規チオ―ル誘導体、その製造法および用途
IT1303737B1 (it) 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
KR101025633B1 (ko) 2002-09-19 2011-03-30 일라이 릴리 앤드 캄파니 오피오이드 수용체 안타고니스트로서의 디아릴 에테르
US7365209B2 (en) 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
ATE406360T1 (de) 2003-03-07 2008-09-15 Lilly Co Eli Antagonisten der opioidrezeptoren
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
MX2007001215A (es) 2004-08-06 2007-04-17 Otsuka Pharma Co Ltd Compuestos aromaticos.
US7709552B2 (en) 2005-02-18 2010-05-04 Nippon Soda Co., Ltd. Organic/inorganic composite
KR20090008217A (ko) 2006-03-10 2009-01-21 오노 야꾸힝 고교 가부시키가이샤 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
JP5128578B2 (ja) 2006-04-04 2013-01-23 エモディス ゲーエムベーハー 解離性障害の治療のためのκ−オピオイド受容体アンタゴニスト含有組成物の利用
JP5345637B2 (ja) 2008-01-22 2013-11-20 イーライ リリー アンド カンパニー κ選択的オピオイド受容体アンタゴニスト
EP2257536A4 (en) 2008-02-14 2011-03-23 Amira Pharmaceuticals Inc CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
CR11559A (es) 2008-03-25 2010-10-20 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
US8048895B2 (en) 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
TWI546290B (zh) 2008-06-27 2016-08-21 賽基艾維洛米斯研究股份有限公司 雜芳基化合物及其用途
JP2012512877A (ja) 2008-12-18 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング セロトニン5−ht2b受容体阻害剤
HN2010001319A (es) 2009-01-26 2013-01-15 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
WO2013059648A1 (en) 2011-10-21 2013-04-25 Neurotherapeutics Pharma, Inc. 2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
CA2886904A1 (en) 2012-10-02 2014-04-10 Cyril Montagne Pyrrolidines
WO2015109080A1 (en) 2014-01-15 2015-07-23 Research Triangle Institute Kappa-opioid receptor selective opioid receptor antagonists
US10118896B2 (en) 2014-11-26 2018-11-06 University Of Kansas Antagonists of the kappa opioid receptor

Also Published As

Publication number Publication date
CN110234638A (zh) 2019-09-13
IL266962A (en) 2019-07-31
JP2019535799A (ja) 2019-12-12
PH12019501172A1 (en) 2019-12-11
MX2019006220A (es) 2019-10-07
JP7051853B2 (ja) 2022-04-11
US20180148432A1 (en) 2018-05-31
HUE061945T2 (hu) 2023-09-28
PT3544972T (pt) 2023-06-20
EP3544972A1 (en) 2019-10-02
US10316021B2 (en) 2019-06-11
CN110234638B (zh) 2022-10-21
IL266962B (en) 2022-02-01
AU2017365123A1 (en) 2019-07-11
NZ754862A (en) 2024-11-29
ES2947293T3 (es) 2023-08-04
EP3544972B8 (en) 2023-06-07
RS64258B1 (sr) 2023-07-31
DK3544972T3 (da) 2023-05-30
TW201831460A (zh) 2018-09-01
WO2018096510A1 (en) 2018-05-31
MX389806B (es) 2025-03-20
EP3544972B1 (en) 2023-04-26
HRP20230518T1 (hr) 2023-08-04
TWI720272B (zh) 2021-03-01
CA3045242A1 (en) 2018-05-31
FI3544972T3 (fi) 2023-06-02
AU2017365123B2 (en) 2022-02-17

Similar Documents

Publication Publication Date Title
PT3544972T (pt) Ligandos opioides capa de heteroaril-fenoxi-benzamida
PL3424053T3 (pl) Drut w postaci ciekłej
GB2571867B (en) Wire strainers
GB2528148B (en) Sustained-release buprenorphine solutions
GB201513850D0 (en) Coordinate positioning machine
GB2547540B (en) Strainers
GB201522437D0 (en) Tethered ligands
GB201514584D0 (en) A gasket
GB201610705D0 (en) A mattress
GB201406237D0 (en) A securable furniture arrangement
GB201509847D0 (en) Anti-dandruff agents
PT3389449T (pt) Um colchão
GB201615838D0 (en) Strainers
GB201509848D0 (en) Anti-dandruff Agents
HK40015851A (en) Heteroarylphenoxy benzamide kappa opioid ligands
GB2548068B (en) A mattress
GB201516302D0 (en) Shower head cover
GB201509849D0 (en) Anti-dandruff agents
ZA201802212B (en) A concealment cover
PL3551025T3 (pl) Zmywarka do naczyń
PL3515274T3 (pl) Zmywarka do naczyń
GB2543370B (en) A gasket arrangement
GB201620135D0 (en) Concept nine
AU5484P (en) Sundrench Fragaria xananassa
AU5613P (en) Florida127 Fragaria xananassa